Szabo, A G, Thorsen, J, Iversen, K F, Levring, M B, Preiss, B, Helleberg, C, Breinholt, M F, Hermansen, E, Gjerdrum, L M R, Bønløkke, S T, Nielsen, K, Kjeldsen, E, Teodorescu, E M, Dokhi, M, Kurt, E, Strandholdt, C N, Andersen, M K & Vangsted, A J 2022, ' The clinical course and life expectancy of patients with multiple myeloma who discontinue their first daratumumab-containing line of therapy ', American Journal of Hematology, vol. 97, no. 3, pp. E117-E120 . https://doi.org/10.1002/ajh.26449 Szabo, A G, Thorsen, J, Iversen, K F, Levring, M B, Preiss, B, Helleberg, C, Breinholt, M F, Hermansen, E, Gjerdrum, L M R, Bønløkke, S, Nielsen, K, Kjeldsen, E, Teodorescu, M, Dokhi, M, Kurt, E, Strandholdt, C N, Andersen, M K & Vangsted, A J 2021, ' The Clinical Course and Life Expectancy of Patients with Multiple Myeloma Who Discontinue Their First Daratumumab-Containing Line of Therapy ', Blood, vol. 138, no. Suppl. 1, 3779 . https://doi.org/10.1182/blood-2021-152070
Højholt, K L, Gregersen, H, Szabo, A G, Klausen, T W, Levring, M B, Preiss, B, Helleberg, C, Breinholt, M F, Hermansen, E, Rahbek Gjerdrum, L M, Bønløkke, S T, Nielsen, K, Kjeldsen, E, Iversen, K F, Teodorescu, E M, Kurt, E, Strandholdt, C, Andersen, M K & Vangsted, A J 2021, ' Outcome of treatment with carfilzomib before and after treatment with daratumumab in relapsed or refractory multiple myeloma patients ', Hematological Oncology, vol. 39, no. 4, pp. 521-528 . https://doi.org/10.1002/hon.2906
Rathe, M, Preiss, B, Marquart, H V H, Schmiegelow, K & Wehner, P S 2020, ' Minimal residual disease monitoring cannot fully replace bone marrow morphology in assessing disease status in pediatric acute lymphoblastic leukemia ', APMIS, vol. 128, no. 5, pp. 414-419 . https://doi.org/10.1111/apm.13037 Rathe, M, Preiss, B, Vibeke Marquart, H, Schmiegelow, K & Skov Wehner, P 2020, ' Minimal residual disease monitoring cannot fully replace bone marrow morphology in assessing disease status in pediatric acute lymphoblastic leukemia ', A P M I S. Acta Pathologica, Microbiologica et Immunologica Scandinavica, vol. 128, no. 5, pp. 414-419 . https://doi.org/10.1111/apm.13037
Molecular Oncology Gammelgaard, O L, Terp, M G, Preiss, B & Ditzel, H J 2018, ' Human cancer evolution in the context of a human immune system in mice ', Molecular Oncology, vol. 12, no. 10, pp. 1797-1810 . https://doi.org/10.1002/1878-0261.12374 Molecular Oncology, Vol 12, Iss 10, Pp 1797-1810 (2018)
Szabo, A G, Klausen, T W, Levring, M B, Preiss, B, Helleberg, C, Breinholt, M F, Hermansen, E, Gjerdrum, L M R, Bønløkke, S T, Nielsen, K, Kjeldsen, E, Iversen, K F, Teodorescu, E M, Dokhi, M, Kurt, E, Strandholdt, C, Andersen, M K & Vangsted, A J 2021, ' The real-world outcomes of multiple myeloma patients treated with daratumumab ', PLoS ONE, vol. 16, no. 10, e0258487 . https://doi.org/10.1371/journal.pone.0258487 PLoS ONE, Vol 16, Iss 10, p e0258487 (2021) Szabo, A G, Klausen, T W, Levring, M B, Preiss, B, Helleberg, C, Breinholt, M F, Hermansen, E, Gjerdrum, L M R, Bønløkke, S T, Nielsen, K, Kjeldsen, E, Iversen, K F, Teodorescu, E M, Dokhi, M, Kurt, E, Strandholdt, C, Andersen, M K & Vangsted, A J 2021, ' The real-world outcomes of multiple myeloma patients treated with daratumumab ', Plos One, vol. 16, no. 10 October, e0258487, pp. 1-11 . https://doi.org/10.1371/journal.pone.0258487 PLoS ONE Szabo, A G, Klausen, T W, Levring, M B, Preiss, B, Helleberg, C, Breinholt, M F, Hermansen, E, Gjerdrum, L M R, Bønløkke, S T, Nielsen, K, Kjeldsen, E, Iversen, K F, Teodorescu, E M, Dokhi, M, Kurt, E, Strandholdt, C, Andersen, M K & Vangsted, A J 2021, ' The real-world outcomes of multiple myeloma patients treated with daratumumab ', PLOS ONE, vol. 16, no. 10, e0258487 . https://doi.org/10.1371/journal.pone.0258487